Skip to content

Binge eating disorder in adolescents

Efficacy of Add-on Homoeopathy and Cognitive Behaviour Therapy in Binge Eating Disorder in adolescents: A Randomized, Single- Blind placebo controlled Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094828
Enrollment
90
Registered
2025-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F508- Other eating disorders

Interventions

Intervention1: Individualized Homoeopathic medicine alongwith Cognitive Behavioural therapy: Individualized Homoeopathic medicines in centesimal potency will be prescribed as per the principles of Hom

Sponsors

Central Council for Research in Homoeopathy, New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participants with ages between 12-18 years, of all gender. 2.Participants meeting Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for Binge Eating Disorder that is Recurrent episodes of binge eating, an episode of which includes eating, in a discrete period of time and a sense of lack of control over eating during the episode also the criteria includes binge-eating episodes which are associated with three (or more) of eating much more rapidly than normal, or eating until feeling uncomfortably full, or eating large amounts of food when not feeling physically hungry, or eating alone because of feeling embarrassed by how much one is eating, or feeling disgusted with oneself, depressed, or very guilty afterwards, or marked distress regarding binge eating is present. Along with this the criteria includes that binge eating occurs, on average, at least once a week for three months and the binge eating is not associated with the recurrent use of inappropriate compensatory behavior (for example, purging) and does not occur exclusively during the course of anorexia nervosa, bulimia nervosa or avoidant/restrictive food intake disorder.

Exclusion criteria

Exclusion criteria: 1.Participants already undergoing treatment (Allopathic, Ayurveda, Homoeopathic) for any other systemic disorders. 2.Participants currently using anti-diabetic medication; contraceptive pills; medications with effect on lipid metabolism i.e. thiazide and loop diuretics, beta and alpha receptor blockers; anti-epileptic drugs, anti-psychotics medications regularly over the last 1 month or more 3.Participants currently using immunosuppressive treatments 4.Morbid obesity BMI greater than 40 kg/m2 5.Severe obesity (BMI greater than 30 kg/m2 ) with related comorbidities such as hypertension or dyslipidemia 6.HbA1c 6.5 percent or higher 7.Hypertriglyceridemia greater than or equal to 130 mg/dL 8.Pregnant and lactating women 9.Participants suffering from systemic and other endocrine disorders e.g. uncontrolled Hypertension, Type I/Type II Diabetes Mellitus, Diabetes Insipidus, Cushing Syndrome, Addison s disease, Insulin Resistance syndrome 10.Participants suffering from other eating disorders such as anorexia nervosa, and bulimia nervosa. 11.Participants with psychiatric disorders viz. schizophrenia, bipolar disorder, Major Depressive Disorder, on medication for depression, anxiety, phobias etc.

Design outcomes

Primary

MeasureTime frame
To assess the changes in symptoms of binge eating disorders using Eating Disorder Examination QuestionnaireTimepoint: Assessed at baseline, 03 months , and 06 months

Secondary

MeasureTime frame
To assess the change in anxiety associated symptoms General Anxiety Disorder-7Timepoint: Assessed at baseline, 03 months , and 06 months;To assess changes in Body Image related aptitudes.Timepoint: Assessed at baseline, 03 months , and 06 months;To assess Lipid profile (Serum triglycerides, LDL, HDL, Total cholesterol), Blood Sugar (Fasting, HbA1c)Timepoint: Assessed at baseline, 03 months , and 06 months.;To assess Blood pressure and ObesityTimepoint: Assessed at every month till 06 months;To assess Serum Fasting Insulin levelsTimepoint: Assessed at baseline and 06 months.;To assess Hormonal profile [Thyroid profile (T3, T4, TSH), FSH, LH, Prolactin, Testosterone, E2 Estradiol, progesterone] for subset of participants (that is participants who are overweight or obese or BMI above 25 kg/m square)Timepoint: Assessed at baseline and 06 months.

Countries

India

Contacts

Public ContactDr Renu Mittal

Central Council for Research in Homoeopathy

drdivyataneja@gmail.com9810305068

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026